Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration
Authors:
- 21 September 2023
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 261 (3) , 361-371
Abstract
Activation and transdifferentiation of hepatic stellate cells (HSC) into migratory myofibroblasts is a key process in liver fibrogenesis. Cell migration requires an active remodeling of the cytoskeleton, which is a tightly regulated process coordinated by Rho‐specific guanine nucleotide exchange factors (GEFs) and the Rho family of small GTPases. Rho‐associated kinase (ROCK) promotes assembly of focal adhesions and actin stress fibers by regulating cytoskeleton organization. GEF exchange protein directly activated by cAMP 1 (EPAC1) has been implicated in modulating TGFβ1 and Rho signaling; however, its role in HSC migration has never been examined. The aim of this study was to evaluate the role of cAMP‐degrading phosphodiesterase 4 (PDE4) enzymes in regulating EPAC1 signaling, HSC migration, and fibrogenesis. We show that PDE4 protein expression is increased in activated HSCs expressing alpha smooth muscle actin and active myosin light chain (MLC) in fibrotic tissues of human nonalcoholic steatohepatitis cirrhosis livers and mouse livers exposed to carbon tetrachloride. In human livers, TGFβ1 levels were highly correlated with PDE4 expression. TGFβ1 treatment of LX2 HSCs decreased levels of cAMP and EPAC1 and increased PDE4D expression. PDE4 specific inhibitor, rolipram, and an EPAC‐specific agonist decreased TGFβ1‐mediated cell migration in vitro. In vivo, targeted delivery of rolipram to the liver prevented fibrogenesis and collagen deposition and decreased the expression of several fibrosis‐related genes, and HSC activation. Proteomic analysis of mouse liver tissues identified the regulation of actin cytoskeleton by the kinase effectors of Rho GTPases as a major pathway impacted by rolipram. Western blot analyses confirmed that PDE4 inhibition decreased active MLC and endothelin 1 levels, key proteins involved in cytoskeleton remodeling and contractility. The current study, for the first time, demonstrates that PDE4 enzymes are expressed in hepatic myofibroblasts and promote cytoskeleton remodeling and HSC migration. © 2023 The Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- National Institutes of Health (P20GM113226, P50AA024337, R01AA029798, R44AA021331, R24AAA025017)
This publication has 65 references indexed in Scilit:
- Adenosine 2A Receptor Antagonist Prevented and Reversed Liver Fibrosis in a Mouse Model of Ethanol-Exacerbated Liver FibrosisPLOS ONE, 2013
- Regulatory Domain Selectivity in the Cell-Type Specific PKN-Dependence of Cell MigrationPLOS ONE, 2011
- S-Adenosylmethionine Decreases Lipopolysaccharide-Induced Phosphodiesterase 4B2 and Attenuates Tumor Necrosis Factor Expression via cAMP/Protein Kinase A PathwayThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Anti-fibrogenic strategies and the regression of fibrosisBest Practice & Research Clinical Gastroenterology, 2011
- Cdc42‐dependent formation of the ZO‐1/MRCKβ complex at the leading edge controls cell migrationThe EMBO Journal, 2011
- Nanoscale architecture of integrin-based cell adhesionsNature, 2010
- Rho‐kinase/ROCK: A key regulator of the cytoskeleton and cell polarityCytoskeleton, 2010
- Toll-Like Receptor Signaling and Liver FibrosisGastroenterology Research and Practice, 2010
- The cyclic AMP effector Epac integrates pro- and anti-fibrotic signalsProceedings of the National Academy of Sciences, 2008
- Adenosine A2Areceptors play a role in the pathogenesis of hepatic cirrhosisBritish Journal of Pharmacology, 2006